Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

Summary by The Manila Times
mRNA-3927 is a strong strategic fit with Recordati’s rare Metabolic portfolio Collaboration combines Moderna’s expertise in mRNA technology for rare metabolic disorders with...

4 Articles

The Manila TimesThe Manila Times
Lean Right

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

mRNA-3927 is a strong strategic fit with Recordati’s rare Metabolic portfolio Collaboration combines Moderna’s expertise in mRNA technology for rare metabolic disorders with...

·Manila, Philippines
Read Full Article
Weatherford DemocratWeatherford Democrat
+2 Reposted by 2 other sources
Lean Left

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)

Moderna will continue to lead clinical development and manufacturing for mRNA-3927

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources lean Left
75% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in on Thursday, January 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Weatherford icon

Weatherford

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal